{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T22:33:24Z","timestamp":1791758004493,"version":"4.3.4"},"reference-count":32,"publisher":"Japanese Society for the Study of Xenobiotics","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[2014]]},"DOI":"10.2133\/dmpk.dmpk-13-rg-045","type":"journal-article","created":{"date-parts":[[2013,7,22]],"date-time":"2013-07-22T19:10:13Z","timestamp":1374520213000},"page":"61-68","source":"Crossref","is-referenced-by-count":24,"title":["Development of an Integrated Population Pharmacokinetic Model for Oral Levetiracetam in Populations of Various Ages and Ethnicities"],"prefix":"10.2133","volume":"29","author":[{"given":"Nathalie","family":"Toublanc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte D.","family":"Lacroix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"900","reference":[{"key":"10.2133\/dmpk.DMPK-13-RG-045_bb0005","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/j.1528-1157.2000.tb04605.x","article-title":"Efficacy and tolerability of levetiracetam 3000 mg\/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group","volume":"41","author":"Ben-Menachem","year":"2000","journal-title":"Epilepsia"},{"key":"10.2133\/dmpk.DMPK-13-RG-045_bb0010","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1212\/WNL.55.2.236","article-title":"Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial","volume":"55","author":"Cereghino","year":"2000","journal-title":"Neurology"},{"key":"10.2133\/dmpk.DMPK-13-RG-045_bb0015","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1528-1157.2000.tb00323.x","article-title":"Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. European Levetiracetam Study Group","volume":"41","author":"Shorvon","year":"2000","journal-title":"Epilepsia"},{"key":"10.2133\/dmpk.DMPK-13-RG-045_bb0020","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1212\/01.wnl.0000217916.00225.3a","article-title":"N159 Study Group: Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures","volume":"66","author":"Glauser","year":"2006","journal-title":"Neurology"},{"key":"10.2133\/dmpk.DMPK-13-RG-045_bb0025","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.1528-1167.2008.01981.x","article-title":"Levetiracetam N01009 Study Group: Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures","volume":"50","author":"Pi\u00f1a-Garza","year":"2009","journal-title":"Epilepsia"},{"key":"10.2133\/dmpk.DMPK-13-RG-045_bb0030","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1212\/01.wnl.0000297512.18364.40","article-title":"N166 Levetiracetam Study Group: Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures","volume":"70","author":"Noachtar","year":"2008","journal-title":"Neurology"},{"key":"10.2133\/dmpk.DMPK-13-RG-045_bb0035","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1212\/01.wnl.0000268699.34614.d3","article-title":"Levetiracetam N01057 Study Group: Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy","volume":"69","author":"Berkovic","year":"2007","journal-title":"Neurology"},{"key":"10.2133\/dmpk.DMPK-13-RG-045_bb0040","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/j.1528-1167.2005.04005.x","article-title":"Fast and sustained efficacy of levetiracetam during titration and the first 3 months of treatment in refractory epilepsy","volume":"46","author":"French","year":"2005","journal-title":"Epilepsia"},{"key":"10.2133\/dmpk.DMPK-13-RG-045_bb0045","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1586\/ecp.09.16","article-title":"Clinical pharmacology of levetiracetam for the treatment ofepilepsy","volume":"2","author":"Stockis","year":"2009","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"10.2133\/dmpk.DMPK-13-RG-045_bb0050","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0163-7258(99)00052-2","article-title":"Pharmacokinetic profile of levetiracetam: toward ideal characteristics","volume":"85","author":"Patsalos","year":"2000","journal-title":"Pharmacol. Ther."},{"key":"10.2133\/dmpk.DMPK-13-RG-045_bb0055","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0920-1211(02)00250-4","article-title":"Effects of antiepileptic comedication on levetiracetam pharmacokinetics: a pooled analysis of data from randomized adjunctive therapy trials","volume":"53","author":"Perucca","year":"2003","journal-title":"Epilepsy Res."},{"key":"10.2133\/dmpk.DMPK-13-RG-045_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2005.01.005","article-title":"Effect of levetiracetam on the pharmacokinetics of adjunctive antiepileptic drugs: a pooled analysis of data from randomized clinical trials","volume":"64","author":"Gidal","year":"2005","journal-title":"Epilepsy Res."},{"key":"10.2133\/dmpk.DMPK-13-RG-045_bb0065","doi-asserted-by":"crossref","first-page":"734744","DOI":"10.1016\/j.clinthera.2006.05.004","article-title":"Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multipledose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects","volume":"28","author":"Ramael","year":"2006","journal-title":"Clin. Ther."},{"key":"10.2133\/dmpk.DMPK-13-RG-045_bb0070","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2165\/00003088-200746060-00004","article-title":"Population pharmacokinetics of levetiracetam in Japanese and Western adults","volume":"46","author":"Pigeolet","year":"2007","journal-title":"Clin. Pharmacokinet."},{"key":"10.2133\/dmpk.DMPK-13-RG-045_bb0075","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2165\/00003088-200847050-00004","article-title":"Retrospective Population Pharmacokinetic Analysis of Levetiracetam in Children and Adolescents with Epilepsy. Dosing Recommendations","volume":"47","author":"Toublanc","year":"2008","journal-title":"Clin. Pharmacokinet."},{"key":"10.2133\/dmpk.DMPK-13-RG-045_bb0080","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00228-003-0655-6","article-title":"Pharmacokinetics and metabolism of 14C-levetiracetam, a new antiepileptic agent, in healthy volunteers","volume":"59","author":"Strolin Benedetti","year":"2003","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.2133\/dmpk.DMPK-13-RG-045_bb0085","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1046\/j.1528-1157.2001.41300.x","article-title":"Pharmacokinetic study of levetiracetam in children","volume":"42","author":"Pellock","year":"2001","journal-title":"Epilepsia"},{"key":"10.2133\/dmpk.DMPK-13-RG-045_bb0090","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.eplepsyres.2006.12.005","article-title":"Prospective assessment of levetiracetam pharmacokinetics during dose escalation in 4\u201312 year old children with partial-onset seizures on concomitant carbamazepine or valproate","volume":"74","author":"Fountain","year":"2007","journal-title":"Epilepsy Res."},{"key":"10.2133\/dmpk.DMPK-13-RG-045_bb0095","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1111\/j.1528-1167.2007.01090.x","article-title":"Pharmacokinetics of levetiracetam in infants and young children with epilepsy","volume":"48","author":"Glauser","year":"2007","journal-title":"Epilepsia"},{"key":"10.2133\/dmpk.DMPK-13-RG-045_bb0100","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2165\/00003088-200443110-00002","article-title":"Clinical pharmacokinetics of levetiracetam","volume":"43","author":"Patsalos","year":"2004","journal-title":"Clin. Pharmacokinet"},{"key":"10.2133\/dmpk.DMPK-13-RG-045_bb0105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3805\/jjes.28.3","article-title":"Multicenter, double-blind, randomized, placebo-controlled study of levetiracetam as add-on therapy in Japanese patients with uncontrolled partial seizures","volume":"28","author":"Yagi","year":"2010","journal-title":"J. Jpn. Epil. Soc."},{"key":"10.2133\/dmpk.DMPK-13-RG-045_bb0110","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3805\/jjes.29.441","article-title":"A multicentre, open-labeled, follow-up trial of levetiracetam in Japanese epilepsy patients with partial onset seizures","volume":"29","author":"Yagi","year":"2012","journal-title":"J. Jpn. Epil. Soc."},{"key":"10.2133\/dmpk.DMPK-13-RG-045_bb0115","series-title":"J.: NONMEM user's guide","author":"Beal","year":"1989"},{"key":"10.2133\/dmpk.DMPK-13-RG-045_bb0120","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.cmpb.2005.04.005","article-title":"PsN-Toolkit\u2014a collection of computer intensive statistical methods for non-linear mixed effects modeling using NONMEM","volume":"79","author":"Lindbom","year":"2005","journal-title":"Comput. Methods Programs Biomed."},{"key":"10.2133\/dmpk.DMPK-13-RG-045_bb0125","unstructured":"R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0. http:\/\/www.R-project.org."},{"key":"10.2133\/dmpk.DMPK-13-RG-045_bb0130","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2165\/00003088-199630050-00001","article-title":"A size standard for pharmacokinetics","volume":"30","author":"Holford","year":"1996","journal-title":"Clin. Pharmacokinet."},{"key":"10.2133\/dmpk.DMPK-13-RG-045_bb0135","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2125.2006.02622.x","article-title":"Prediction of drug clearance in children from adults: a comparison of several allometric methods","volume":"61","author":"Mahmood","year":"2006","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.2133\/dmpk.DMPK-13-RG-045_bb0140","series-title":"National growth survey on preschool children","article-title":"Ministry of Health, Labour and Welfare (NHLW) Japan","year":"2000"},{"key":"10.2133\/dmpk.DMPK-13-RG-045_bb0145","series-title":"School health survey report","article-title":"Japanese Ministry of Education, Culture, Sports, Science and Technology","year":"2000"},{"key":"10.2133\/dmpk.DMPK-13-RG-045_bb0150","unstructured":"Regulation (EC) No 1901\/2006 of the European Parliament and of the Council. 12 December 2006 with amendment 20 December 2006."},{"key":"10.2133\/dmpk.DMPK-13-RG-045_bb0155","unstructured":"US Pediatric Research Equity Act (Public Law 108\u2013155) 03 December 2003."},{"key":"10.2133\/dmpk.DMPK-13-RG-045_bb0160","article-title":"Population pharmacokinetic analysis of levetiracetam in pediatric patients with epilepsy aged 1 month to 16 years","author":"Toublanc","year":"2008"}],"container-title":["Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1347436715302962?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1347436715302962?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2017,6,21]],"date-time":"2017-06-21T12:37:49Z","timestamp":1498048669000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347436715302962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014]]}},"alternative-id":["S1347436715302962"],"URL":"https:\/\/doi.org\/10.2133\/dmpk.dmpk-13-rg-045","relation":{},"ISSN":["1347-4367"],"issn-type":[{"value":"1347-4367","type":"print"}],"subject":[],"published":{"date-parts":[[2014]]}}}